Segall Bryant Hamill Limited Liability accumulated 63,346 shares or 0.19% of the stock.
In the market the company is trading up by 1.90% since yesterday's close of $54.24. This represents a $1.56 dividend on an annualized basis and a yield of 2.74%. It has underperformed by 19.46% the S&P500. On average, equities analysts predict that Bristol-Myers Squibb Company will post $2.96 earnings per share for the current fiscal year. Therefore 64% are positive.
02/02/2017 - Bristol-Myers Squibb Company had its " rating reiterated by analysts at UBS. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has "Buy" rating given on Monday, December 19 by Jefferies. The firm has "Buy" rating given on Friday, January 22 by Berenberg. Stifel Nicolaus maintained Endologix, Inc. They set an "outperform" rating for the company. (NASDAQ:ELGX) earned "Hold" rating by Stifel Nicolaus on Thursday, May 18. Argus Research maintained Pfizer Inc. If the market is performing well and the stock is over-valued, BMY might be a good investment at this point but if the market is dropping down, you might not consider buying the stock. The firm has "Hold" rating given on Tuesday, March 15 by Jefferies. SunTrust initiated the stock with "Neutral" rating in Wednesday, January 6 report. Barclays Capital maintained the shares of BMY in report on Tuesday, December 1 with "Equal Weight" rating. Its up 0.03, from 0.85 in 2016Q3. Davidson Invest Advisors reported 1,850 shares. 42 funds opened positions while 95 raised stakes. Moreover, State Board Of Administration Of Florida Retirement System has 0% invested in Endologix, Inc. Rail stated it has 7,700 shares or 0.33% of all its holdings. Dodge And Cox holds 0.01% or 85,065 shares in its portfolio. William Blair analyst M. Phipps now expects that the biopharmaceutical company will earn $0.75 per share for the quarter, up from their prior estimate of $0.71. Going back previous 30 days we noticed that BMY performed along premium change of 1.93%. Brandes Prtnrs Lp has invested 2.57% in Pfizer Inc. Credit Agricole S A has invested 0.45% in McDonald's Corporation (NYSE:MCD). Ferguson Wellman Mgmt holds 128,791 shares or 0.31% of its portfolio. The return on assets ratio shows how well management is employing the company's total assets to make a profit. Hermes Invest Management reported 567,050 shares. United Automobile Association reported 0% stake. Curbstone Fin reported 6,444 shares or 0.24% of all its holdings. Vereit Inc. was reduced too. About 245,093 shares traded.More news: Coutinho transfer: Will Liverpool lose their man?
The SMA20 for the stock is at 2.67 percent, SMA50 stands at 3.66 percent, while SMA200 is 3.92 Percent. 538.67 million shares or 0.04% more from 538.45 million shares in 2016Q3 were reported. It dropped, as 86 investors sold BMY shares while 529 reduced holdings. 112 funds opened positions while 441 raised stakes. Montecito Savings Bank Trust has 26,597 shares. Daiwa Sb Investments accumulated 151,050 shares. 88,673 were reported by Amica Mutual Insurance. Welch Investments LLC acquired a new stake in shares of Bristol-Myers Squibb during the fourth quarter worth $119,000. Bristol-Myers Squibb's dividend payout ratio is now 56.73%. Finally, Intellectus Partners LLC purchased a new stake in Bristol-Myers Squibb during the fourth quarter worth approximately $227,000. Braun Stacey Associate Incorporated holds 1.09% or 123,851 shares in its portfolio. The original version of this article can be viewed at https://www.com-unik.info/2017/08/01/exane-derivatives-has-313000-stake-in-bristol-myers-squibb-company-nysebmy-updated.html. Geduld E E has 47,500 shares for 1.56% of their portfolio. 15,355 are held by Intersect Cap Limited Co. It also upped Snap (NYSE:SNA) stake by 20,945 shares and now owns 155,005 shares.
Since February 27, 2017, it had 1 buy, and 6 insider sales for $9.91 million activity. About 4.54 million shares traded. $681,240 worth of stock was bought by Samuels Theodore R. II on Monday, February 27. $2.30 million worth of Home Depot Inc (NYSE:HD) shares were sold by Carey Matt. Caldarella Joseph C had sold 8,096 shares worth $463,779.
Recent session action on shares of Bristol-Myers Squibb Company (NYSE:BMY) puts the stock on today's active list. Therefore 32% are positive.More news: Forecast: Decent chance of precipitation Wednesday night
Bristol-Myers Squibb Company's ROA is 13.77%, while industry's average is -6.5%. The rating was maintained by Jefferies on Thursday, August 11 with "Hold".
Bristol-Myers Squibb (NYSE:BMY) last released its quarterly earnings results on Thursday, July 27th. The rating was maintained by Citigroup on Tuesday, September 20 with "Buy". Piper Jaffray upgraded the stock to "Underweight" rating in Monday, August 24 report. The firm has "Sell" rating by Societe Generale given on Wednesday, April 6. William Blair also issued estimates for Bristol-Myers Squibb's Q4 2017 earnings at $0.66 EPS, FY2017 earnings at $2.99 EPS, FY2018 earnings at $3.02 EPS, FY2019 earnings at $3.71 EPS and FY2020 earnings at $3.98 EPS. The firm earned "Sell" rating on Wednesday, April 6 by Societe Generale. Deutsche Bank maintained McDonald's Corporation (NYSE:MCD) rating on Monday, April 25.More news: Macklemore hit by an alleged drunk driver
- Pak lawmaker accuses Imran of harassing women party leaders
- Netflix Releases Thrilling First Trailer for David Fincher's 'Mindhunter'
- Jab Harry Met Sejal: Tickets booked? Check what's in store for you!
- Government not serious about Backward Classes bill: Chidambaram
- Trump drops to new low in Rasmussen poll
- Video of boy with Down syndrome singing goes viral
- Jadon Sancho misses training on several occasions amidst Arsenal and Tottenham links
- Jason Bateman Teases 'Arrested Development' Season 5 With New Photo
- Bentley Gives the Flying Spur V8 S a Mild Sport Injection
- Julian Edelman, Stephon Gilmore tossed from practice after tussle